Success story : Biomunex Pharmaceuticals

January 2024

A few months ago, in one of the last DYSL Pierre-Emmanuel Gerard, presented the key issues of BIOMUNEX PHARMACEUTICALS.

Very happy to share today this excellente news for the development of #Biomunex.

For more than 5 years, with one of our key Expert-in-Residence, Stéphane MILOT, with Loïc MOULARD also for a few months, at the helm of the outsourced Financial Department, as well as our support around different strategic and operational perspectives, #LallianSe is pleased to contribute to the success of Biomunex.

Congratulations to the entire team for starting this clinical study ! 👏

Find out more👉

#Partnership #innovation #biotech #healthcare #immunotherapy #XIR

Do you speak LallianSe ? #24 Benjamin Pruvost, FRM

Since its creation in 1947, by supporting research, the Fondation pour la Recherche Médicale plays a crucial role in the development of research projects and support for researchers. 

The #valorization of this work represents a strategic and significant approach while resulting from a plural and complex process. This is why, with our know-how and our tailor-made courses, #LallianSe has been supporting the #FRM for several years to initiate, explore and develop its inspiring and original approach, making it a unique player in the valorization and maturation of biomedical research projects.

More than a #collaboration, this relationship is based on common values and a shared ambition. We are proud to count the #FRM among our #partners.

Meet Benjamin PRUVOST in our #𝐃𝐨𝐘𝐨𝐮𝐒𝐩𝐞𝐚𝐤𝐋𝐚𝐥𝐥𝐢𝐚𝐧𝐒𝐞?

#health #DYSL #team #foundation #network #community